Article
An observational study of high- and low-abundance anti-retroviral resistance mutations among treatment-naïve people living with HIV in New Zealand between 2012 and 2017.
Internal medicine journal - 1 Jul 2020
Young Nicholas, Hobbs Mark, Rahnama Fahimeh, Shi Jinyang, Briggs Simon
Abstract excerpt
HIV resistance genotyping detects drug resistance mutations (DRMs) in ≥20% of circulating virus within an infected individual (high-abundance DRMs). Deep sequencing also detects DRMs in smaller viral subpopulations (low-abundance DRMs), although these are of uncertain importance. In this retrospective analysis of 292 treatment-naïve patients, high-abundance DRMs were present in 30/292 (10%) patients, but only one...
Topics
- Drug Resistance, Viral
- Genotype
- HIV Infections
- HIV-1
- Humans
- Mutation
- New Zealand
- Retrospective Studies
